D. Morel

741 total citations
28 papers, 382 citations indexed

About

D. Morel is a scholar working on Nephrology, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, D. Morel has authored 28 papers receiving a total of 382 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Nephrology, 9 papers in Pulmonary and Respiratory Medicine and 5 papers in Epidemiology. Recurrent topics in D. Morel's work include Cytomegalovirus and herpesvirus research (4 papers), Viral-associated cancers and disorders (3 papers) and Renal and Vascular Pathologies (3 papers). D. Morel is often cited by papers focused on Cytomegalovirus and herpesvirus research (4 papers), Viral-associated cancers and disorders (3 papers) and Renal and Vascular Pathologies (3 papers). D. Morel collaborates with scholars based in France, United States and Mali. D. Morel's co-authors include L. Potaux, Pierre Merville, Lionel Couzi, N. Grenier, J. Ferrière, C. Douws, M. Le Guillou, M. Aparicio, Séverine Martin and Marie‐Edith Lafon and has published in prestigious journals such as Radiology, American Journal of Transplantation and Journal of Thrombosis and Haemostasis.

In The Last Decade

D. Morel

28 papers receiving 362 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D. Morel France 11 118 96 73 65 62 28 382
Stephen D. Migdal United States 12 98 0.8× 74 0.8× 98 1.3× 127 2.0× 36 0.6× 17 422
J.M. Chalopin France 13 119 1.0× 50 0.5× 111 1.5× 93 1.4× 75 1.2× 28 491
P. Peyronnet France 11 65 0.6× 83 0.9× 76 1.0× 94 1.4× 36 0.6× 20 408
Leonard C. Hymes United States 15 94 0.8× 107 1.1× 111 1.5× 131 2.0× 119 1.9× 37 562
Khalid Almeshari Saudi Arabia 9 110 0.9× 56 0.6× 65 0.9× 38 0.6× 117 1.9× 24 357
J.M. Goujon France 11 39 0.3× 63 0.7× 133 1.8× 63 1.0× 32 0.5× 18 430
Nauman Siddiqi Saudi Arabia 7 82 0.7× 83 0.9× 82 1.1× 107 1.6× 60 1.0× 9 465
Karla Laís Pêgas Brazil 10 73 0.6× 113 1.2× 110 1.5× 74 1.1× 38 0.6× 44 405
J. S. Cheigh United States 10 94 0.8× 68 0.7× 75 1.0× 54 0.8× 23 0.4× 20 365
J Luciani France 9 120 1.0× 61 0.6× 81 1.1× 21 0.3× 31 0.5× 47 324

Countries citing papers authored by D. Morel

Since Specialization
Citations

This map shows the geographic impact of D. Morel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Morel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Morel more than expected).

Fields of papers citing papers by D. Morel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Morel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Morel. The network helps show where D. Morel may publish in the future.

Co-authorship network of co-authors of D. Morel

This figure shows the co-authorship network connecting the top 25 collaborators of D. Morel. A scholar is included among the top collaborators of D. Morel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Morel. D. Morel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Aparicio, M., H. Gin, V. de Précigout, et al.. (2015). Compliance with Low-Protein Diet by Uremic Patients: Three Years� Experience. Contributions to nephrology. 81. 71–78. 1 indexed citations
2.
Couzi, Lionel, Thomas Bachelet, Séverine Martin, et al.. (2012). Preemptive Therapy Versus Valgancyclovir Prophylaxis in Cytomegalovirus-positive Kidney Transplant Recipients Receiving Antithymocyte Globulin Induction. Transplantation Proceedings. 44(9). 2809–2813. 22 indexed citations
3.
Couzi, Lionel, Thomas Bachelet, Karine Moreau, et al.. (2011). High Incidence of Anticytomegalovirus Drug Resistance Among D+R− Kidney Transplant Recipients Receiving Preemptive Therapy. American Journal of Transplantation. 12(1). 202–209. 60 indexed citations
4.
Nurden, Paquita, Narendra N. Tandon, Hisao Takizawa, et al.. (2009). An acquired inhibitor to the GPVI platelet collagen receptor in a patient with lupus nephritis. Journal of Thrombosis and Haemostasis. 7(9). 1541–1549. 27 indexed citations
5.
Couzi, Lionel, D. Morel, Colette Deminière, & Pierre Merville. (2004). An unusual endocarditis-induced crescentic glomerulonephritis treated by plasmapheresis. Clinical Nephrology. 62(12). 461–464. 16 indexed citations
6.
Rolland, Yan, et al.. (2002). [Efficacy of C1-C2 block with posterior parasagittal approach in the treatment of Arnold neuralgia in 24 patients].. PubMed. 83(2 Pt 1). 133–9. 4 indexed citations
7.
Bonarek, Hervé, Pierre Merville, M. Bonarek, et al.. (2000). Improvement of parathyroid function after kidney transplantation: effect on parathyroid functional mass. Transplantation Proceedings. 32(2). 401–403. 1 indexed citations
8.
Morel, D., et al.. (1999). Recurrent renal failure associated with hypersensitivity to allopurinol. Nephrology Dialysis Transplantation. 14(3). 780–781. 7 indexed citations
9.
Malvy, Denis, et al.. (1999). [Kidney transplantation and travel in the tropics].. PubMed. 20(3). 145–51. 3 indexed citations
10.
Merville, Pierre, et al.. (1997). A renal transplant recipient with acute paraparesis due to an Aspergillus epidural abscess. Nephrology Dialysis Transplantation. 12(10). 2185–2187. 10 indexed citations
11.
Merville, Pierre, et al.. (1997). Xanthogranulomatous pyelonephritis in the native kidney of a renal transplant recipient. Nephrology Dialysis Transplantation. 12(4). 831–832. 1 indexed citations
12.
Morel, D., Pierre Merville, Brigitte Le Bail, et al.. (1996). Epstein-Barr virus (EBV)-associated hepatic and splenic smooth muscle tumours after kidney transplantation. Nephrology Dialysis Transplantation. 11(9). 1864–1866. 21 indexed citations
13.
Combe, Christian, D. Morel, V. de Précigout, et al.. (1995). Long-Term Control of Hyperparathyroidism in Advanced Renal Failure by Low-Phosphorus Low-Protein Diet Supplemented with Calcium (without Changes in Plasma Calcitriol). ˜The œNephron journals/Nephron journals. 70(3). 287–295. 38 indexed citations
14.
Guen, Emmanuel Le, D. Morel, B. L’Azou, J. Cambar, & L. Potaux. (1994). Effect of cyclosporin and the prostacydin analogue iloprost on human glomerular vasoreactivity. Nephrology Dialysis Transplantation. 9(4). 413–415. 4 indexed citations
15.
Morel, D., et al.. (1993). Effect of famotidine on renal transplant patients treated with ciclosporine A. Fundamental and Clinical Pharmacology. 7(3-4). 167–170. 1 indexed citations
16.
Guen, Emmanuel Le, et al.. (1992). Fatal varicella or Reye's syndrome: an unusual cause of death in a renal graft recipient. Nephrology Dialysis Transplantation. 7(2). 158–160. 4 indexed citations
17.
Grenier, N., C. Douws, D. Morel, et al.. (1991). Detection of vascular complications in renal allografts with color Doppler flow imaging.. Radiology. 178(1). 217–223. 71 indexed citations
18.
Couet, William, et al.. (1990). Effect of ponsinomycin on cyclosporin pharmacokinetics. European Journal of Clinical Pharmacology. 39(2). 165–167. 18 indexed citations
19.
Pillot, J, et al.. (1990). [Prevalence of hepatitis B virus in women of childbearing age in Mali].. PubMed. 83(1). 93–9. 2 indexed citations
20.
Aparicio, M., H. Gin, L. Potaux, et al.. (1988). Effect of a Low-Protein Diet on Urinary Albumin Excretion in Uremic Patients. ˜The œNephron journals/Nephron journals. 50(4). 288–291. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Stephen D. Migdal Breakdown of academic impact, for papers by J.M. Chalopin Breakdown of academic impact, for papers by P. Peyronnet Breakdown of academic impact, for papers by Leonard C. Hymes Breakdown of academic impact, for papers by Khalid Almeshari Breakdown of academic impact, for papers by J.M. Goujon Breakdown of academic impact, for papers by Nauman Siddiqi Breakdown of academic impact, for papers by Karla Laís Pêgas Breakdown of academic impact, for papers by J. S. Cheigh Breakdown of academic impact, for papers by J Luciani
Rankless by CCL
2026